Preparation of an R3 reagent (serum depleted of the third component of human complement (C3)) by immunoadsorption. Application to the hemolytic assay of human C3.

No abstract is available for this paper.

• Publication year

  1980

• Venue

  JIM - Journal of Immunological Methods

• Publication date

  1980-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0022-1759(80)80005-6PMID 6989915
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bactericidal activity of the alternative complement pathway generated from 11 isolated plasma proteins

  1979cited by this paper
• A study of the breakdown of the third component of human complement (C3).

  1979cited by this paper
• A radial hemolysis method in agarose for the functional assay of properdin.

  1978cited by this paper
• Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution

  1977cited by this paper
• A simple one-step hemolytic assay for C2 with C2-deficient human serum.

  1977cited by this paper
• The role of membrane receptors for C3b and C3d in phagocytosis

  1977cited by this paper
• Third component of human complement: purification from plasma and physicochemical characterization.

  1976cited by this paper
• Release of histamine from rat mast cells by the complement peptides C3a and C5a.

  1975cited by this paper
• Physico-chemical and antigenic properties of human C3.

  1975cited by this paper
• A simplified method for cyanogen bromide activation of agarose for affinity chromatography.

  1974cited by this paper
• COMPLEMENT-DEPENDENT B-CELL ACTIVATION BY COBRA VENOM FACTOR AND OTHER MITOGENS?

  1974cited by this paper
• Polyacrylamide Gel Electrophoresis (PAGE) of Reduced and Dissociated C3 and C5: Studies of the Polypeptide Chain (PPC) Subunits and Their Modifications by Trypsin (TRY) and C4̄2̄-4̄2̄3̄.

  1973cited by this paper
• The separation of nine components and two inactivators of components of complement in humansserum.

  1970cited by this paper
• Serum C'3 Lytic System in Patients with Glomerulonephritis

  1969cited by this paper
• The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

  1969cited by this paper
• ISOLATION OF A FRAGMENT (C3a) OF THE THIRD COMPONENT OF HUMAN COMPLEMENT CONTAINING ANAPHYLATOXIN AND CHEMOTACTIC ACTIVITY AND DESCRIPTION OF AN ANAPHYLATOXIN INACTIVATOR OF HUMAN SERUM

  1969cited by this paper
• Complement dependent immune phagocytosis. I. Requirements for C'1, C'4, C'2, C'3.

  1968cited by this paper
• THE DERIVATION OF TWO DISTINCT ANAPHYLATOXIN ACTIVITIES FROM THE THIRD AND FIFTH COMPONENTS OF HUMAN COMPLEMENT

  1968cited by this paper
• Physico-chemical characteristics of the third and fourth component of complement after dissociation from complement-cell complexes.

  1967cited by this paper
• COMPLEMENT AS A MEDIATOR OF INFLAMMATION

  1967cited by this paper
• COMPLEMENT AS A MEDIATOR OF INFLAMMATION

  1967cited by this paper

• The effects of five different glycans on innate immune responses by phagocytes of hybrid tilapia and Japanese eels Anguilla japonica.

  2007cites this paper
• Localization of a hydrophobic domain in human C5.

  1988cites this paper
• Peptidoglycan isolated fromLactobacillus bulgaricus: Complement-mediated effect on maturation of precursor T cells

  1987cites this paper
• Long-term biosynthesis of complement component C3 and alpha-1 acid glycoprotein by adult rat hepatocytes in a co-culture system with an epithelial liver cell-type.

  1986cites this paper
• Biosynthesis of the third component of complement (C3) by the human monocytic-cell line U-937. Induction by phorbol myristate acetate.

  1986cites this paper
• Modulation of complement receptors of a human monocyte cell line, U‐937, during incubation with phorbol myristate acetate: expression of an iC3b‐specific receptor (CR3)

  1985cites this paper
• Hemolytic plate assay for quantification of active human complement component C3 using methylamine-treated plasma as complement source.

  1985cites this paper
• Isolation of two molecular populations of human complement factor H by hydrophobic affinity chromatography.

  1984cites this paper
• Localisation of a group of antigenic sites in complement component C3, and identification of a new fragmentation pattern.

  1984cites this paper
• Inhibition of neutrophil function by fluid phase C3b of complement

  1983cites this paper
• A hemolytic assay for clinical investigation of human C2.

  1983cites this paper
• Regulation of the Binding of C3‐Coated Particles to Human Lymphocytes by Human Complement Component H *

  1983cites this paper
• Molecular titration of components of the classical complement pathway.

  1983cites this paper
• [Substances contained in the coelomic fluid of Lumbricus terristris having functions in common with those of some human complement components].

  1983cites this paper
• Partial deficiency of the fourth component of human complement (C4) and autoantibody directed against C4 in a patient with SLE.

  1983cites this paper
• Mise en évidence de substances contenues dans le liquide cœlomique de Lumbricus terrestris, possédant des fonctions communes avec celles de certains composants du complément humain

  1983cites this paper
• Structure-function relations in the third component of human complement (C3)-I. Hydrophobic site.

  1982cites this paper
• Purification of complement components by hydrophobic affinity chromatography on phenyl—Sepharose

  1982cites this paper
• Sensitive one-step haemolytic assays of the fourth (C4) and fifth (C5) components of the human complement system.

  1982cites this paper
• Interactions of the third component of human complement (C3) with tumour cells: evidence for presence of C3b acceptor sites and direct activation of C3 by tumour cells.

  1981cites this paper
• Inter-alpha-trypsin-inhibitor (ITI): use of immunoadsorbents for preparation of anti-ITI antiserum, ITI-free human serum and purified ITI.

  1981cites this paper
• A common antigenic determinant on human C4b and C3b.

  1980cites this paper